Solid Biosciences Inc.
SLDB· Nasdaq
Released Aug 14, 2023, after the close
10-Q filed Aug 14, 2023, 45 days after period end · 0000950170-23-042371
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$24.63M | -$25.09M | -$18.70M | -$18.99M |
| EPS Diluted | -$1.25 | -$3.33 |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.